C5366

Chlorisondamine diiodide

Name: Chlorisondamine diiodide
Brand: SIGMA

≥98% (HPLC), nicotinic acetylcholine receptor antagonist, solid

Sinónimos:

4,5,6,7-Tetrachloro-2,3-dihydro-2-methyl-2-[2-(trimethylammonio)ethyl]-2H-isoindolium diiodide

Slide 1 of 1

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

En este momento no podemos mostrarle ni los precios ni la disponibilidad

Acerca de este artículo

Fórmula empírica (notación de Hill):

C₁₄H₂₀Cl₄I₂N₂

Número CAS:

96750-66-2

Peso molecular:

611.94

UNSPSC Code:

12352116

PubChem Substance ID:

24724443

NACRES:

NA.77

MDL number:

MFCD01074794

Assay:

≥98% (HPLC)

Form:

solid

Quality level:

200

Storage condition:

protect from light

Documentos clave

Ver Toda la documentación

Saltar a

Servicio técnico

¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.

Permítanos ayudarle

Nombre del producto

Chlorisondamine diiodide, ≥98% (HPLC), white, solid

Quality Level

200

assay

≥98% (HPLC)

form

solid

storage condition

protect from light

color

white

solubility

H₂O: ≥2 mg/mL, DMSO: >20 mg/mL

storage temp.

2-8°C

SMILES string

[I-].[I-].C[N+](C)(C)CC[N+]1(C)Cc2c(Cl)c(Cl)c(Cl)c(Cl)c2C1

InChI

1S/C14H20Cl4N2.2HI/c1-19(2,3)5-6-20(4)7-9-10(8-20)12(16)14(18)13(17)11(9)15;;/h5-8H2,1-4H3;2*1H/q+2;;/p-2

InChI key

FPNVAOZHQUJJJQ-UHFFFAOYSA-L

Categorías relacionadas

Bioactive Small Molecules

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 4

Este artículo	SML1402	A9605	N8914
Sigma-Aldrich C5366 Chlorisondamine diiodide	Sigma-Aldrich SML1402 TCID	Sigma-Aldrich A9605 AC-93253 iodide	Sigma-Aldrich N8914 NSC308848
form solid	form powder	form solid	form powder
assay ≥98% (HPLC)	assay ≥98% (HPLC)	assay ≥98% (HPLC)	assay ≥98% (HPLC)
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C
solubility H₂O: ≥2 mg/mL, DMSO: >20 mg/mL	solubility DMSO: 5 mg/mL, clear	solubility DMSO: >10 mg/mL, H₂O: insoluble	solubility DMSO: >20 mg/mL
storage condition protect from light	storage condition -	storage condition desiccated	storage condition protect from light
color white	color white to light brown	color dark purple	color yellow

Application

Chlorisondamine diiodide has been used:

as a nicotinic receptor antagonist to test its effect on trinitrobenzene sulfonic acid (TNBS)-induced colitis[1]
as an irreversible nicotinic acetylcholine(nAChR) blocker to pre-treat brain samples to test its effect on cytochrome P450 2B (CYP2B) induction[2]
as a ganglionic blocker to test its effect on regulating corticosterone levels in rat with chronic stress[3]

Biochem/physiol Actions

Chlorisondamine diiodide mediates ganglionic and central blockade.[4]

Irreversible, long-lasting nicotinic acetylcholine receptor antagonist.

Features and Benefits

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the Acetylcholine Receptors (Nicotinic) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

pictograms

GHS07,GHS09

signalword

Warning

hcodes

H302,H400

pcodes

P273 - P301 + P312 + P330

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1

Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

The effect of the cholinergic anti-inflammatory pathway on experimental colitis.

A Bai et al.

Scandinavian journal of immunology, 66(5), 538-545 (2007-10-24)

Inflammatory bowel diseases (IBD) are characterized by proinflammatory cytokines, tissue damage and loss of neuron in inflamed mucosa, which implies the cholinergic anti-inflammatory pathway may be destroyed during the process of inflammatory response. In the study, we identified the effect

Discriminative stimulus effects of mecamylamine and nicotine in rhesus monkeys: Central and peripheral mechanisms.

Colin S Cunningham et al.

Pharmacology, biochemistry, and behavior, 179, 27-33 (2019-02-10)

Mecamylamine is a non-competitive nicotinic acetylcholine receptor (nAChR) antagonist that has been prescribed for hypertension and as an off-label smoking cessation aid. Here, we examined pharmacological mechanisms underlying the interoceptive effects (i.e., discriminative stimulus effects) of mecamylamine (5.6 mg/kg s.c.)

Sympathetic nervous system contributes to enhanced corticosterone levels following chronic stress.

Steven A Lowrance et al.

Psychoneuroendocrinology, 68, 163-170 (2016-03-15)

Exposure to chronic stress often elevates basal circulating glucocorticoids during the circadian nadir and leads to exaggerated glucocorticoid production following exposure to subsequent stressors. While glucocorticoid production is primarily mediated by the hypothalamic-pituitary-adrenal (HPA) axis, there is evidence that the

Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.

Kathryn K Chadman et al.

The Journal of pharmacology and experimental therapeutics, 308(1), 73-78 (2003-10-21)

Chlorisondamine and mecamylamine are nicotinic antagonists that produce both ganglionic and central blockade. Chlorisondamine, when administered as a large systemic dose, produces a persistent central block, despite being charged. The present study evaluated the cardiovascular effects of chlorisondamine. Shortly after

Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons.

T Mori et al.

Molecular pharmacology, 59(4), 732-743 (2001-03-22)

Inhalational general anesthetics have recently been shown to inhibit neuronal nicotinic acetylcholine (ACh) receptors (nnAChRs) expressed in Xenopus laevis oocytes and in molluscan neurons. However, drug actions on these systems are not necessarily the same as those seen on native

Ver todos los artículos relacionados

Artículos

DISCOVER Bioactive Small Molecules for Neuroscience

Número de artículo de comercio global

SKU	GTIN
C5366-10MG	04061832081601
C5366-50MG	04061832081618

Preguntas

Revisiones

Sin puntuación

Filtros activos

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico